2003
DOI: 10.1093/humrep/deg291
|View full text |Cite
|
Sign up to set email alerts
|

Evidence that oxytocin is a physiological component of LH regulation in non-pregnant women

Abstract: The results indicated that inhibition of endogenous oxytocin affects the endocrinology of the ovulatory cycle in women, and strongly suggest that oxytocin has a role in the physiological processes of LH regulation.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
29
0

Year Published

2006
2006
2022
2022

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 35 publications
(30 citation statements)
references
References 32 publications
1
29
0
Order By: Relevance
“…It has been shown that oxytocin promotes the LH surge during the follicular phase [21], and that the maximum LH levels are reduced after administration of the oxytocin antagonist atosiban in healthy volunteers [22]. Atosiban has also been shown to inhibit FSH release, but with a less significant effect than that seen for LH [22]. In the present study we found higher concentrations of FSH during the menstrual and early follicular phases as well as a higher concentration of 17b-E 2 during the late follicular phase in dysmenorrheic patients.…”
Section: Discussionmentioning
confidence: 99%
“…It has been shown that oxytocin promotes the LH surge during the follicular phase [21], and that the maximum LH levels are reduced after administration of the oxytocin antagonist atosiban in healthy volunteers [22]. Atosiban has also been shown to inhibit FSH release, but with a less significant effect than that seen for LH [22]. In the present study we found higher concentrations of FSH during the menstrual and early follicular phases as well as a higher concentration of 17b-E 2 during the late follicular phase in dysmenorrheic patients.…”
Section: Discussionmentioning
confidence: 99%
“…Thus, OXT can modulate ACTH and cortisol secretion to mobilize body function but curbs its potentially harmful consequence. In addition, OXT is also found to increase the release of prolactin [58, 59], α -MSH [60], LH [61], and FSH [62] as well as its own release [4, 63]. On the contrary, OXT inhibits TSH [64] and GH [65] release.…”
Section: Effects On Endocrine Systemsmentioning
confidence: 99%
“…Thus, plasma OXT fluctuates throughout the menstrual cycle in normally cycling healthy fertile women. OXT can advance the LH surge; conversely, OXTR antagonists inhibit full production of the LH surge [61]. Thus, the high level of OXT before luteal phase has a role in the physiological processes of LH regulation; therefore OXT can modulate ovulation and the ensuing pregnancy.…”
Section: Reproductive Functionsmentioning
confidence: 99%
“…HIV, seizures, cardiovascular, kidney or endocrine diseases, diabetes, high blood pressure, and history of head trauma or loss of consciousness > 20 minutes) and current use of prescription medication. Female participants were excluded for the following reasons: (i) the male to female ratio for ASPD is 9 to 1, respectively (APA, 2000), thus female participants would be not representative of the target populations desired in this study, (ii) the neuropeptide oxytocin increases levels of luteinizing hormone (Evans, Reid, Wakeman, Croft, & Benny, 2003) which could potentially affect the regularly occurring menstrual cycles of female participants, and (iii) to our knowledge there are no reports of the interactions of oxytocin administration with oral contraceptives (i.e. birth control), thus behavioral and physiological side effects are unknown.…”
Section: Methodsmentioning
confidence: 99%